Gemcitabine is a potent radiosensitizer in both laboratory studies and in the clinic. Initial laboratory studies showed that gemcitabine radiosensitizes a wide variety of rodent and human tumor cells in culture. Maximum
Donna S. Shewach, PhD
Advertisement
Articles by Donna S. Shewach, PhD
Advertisement
Latest Updated Articles
- Radiosensitization by Gemcitabine
Published: October 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
3
SCT with Melphalan/Ascorbic Acid Safe for BRCA-Mutated PDAC
4
Clinical Implications Remain After Dasatinib CRL in CML/ALL
5
